Reactivation of resolved hepatitis B virus infection after allogeneic haematopoietic stem cell transplantation (Q45669127)

15 December 2017

title

Reactivation of resolved hepatitis B virus infection after allogeneic haematopoietic stem cell transplantation (English)

1 reference

15 December 2017

1 reference

1 reference

Knöll A

1

1 reference

15 December 2017

Boehm S

2

1 reference

15 December 2017

Hahn J

3

1 reference

15 December 2017

Holler E

4

1 reference

15 December 2017

Jilg W

5

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

Bone Marrow Transplantation

15 December 2017

published in

1 reference

15 December 2017

volume

33

1 reference

15 December 2017

issue

9

1 reference

15 December 2017

page(s)

925-929

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704457

15 December 2017

exact match

0 references

cites work

Hepatic events after bone marrow transplantation in patients with hepatitis B infection: a case controlled study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704457

Hepatitis B virus persistence after recovery from acute viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704457

The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704457

Sensitive and accurate quantitation of hepatitis B virus DNA using a kinetic fluorescence detection system (TaqMan PCR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704457

Reverse seroconversion of hepatitis B after allogeneic bone marrow transplantation: a retrospective study of 37 patients with pretransplant anti-HBs and anti-HBc

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704457

Hepatitis B virus reactivation with clinical flare in allogeneic stem cell transplants with chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704457

Lamivudine treatment for chronic replicative hepatitis B virus infection after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704457

Fulminant hepatitis B following bone marrow transplantation in an HBsAg-negative, HBsAb-positive recipient; reactivation of dormant virus during the immunosuppressive period

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704457

Reactivation of hepatitis B virus infection in an anti-HBc and anti-HBs positive patient after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704457

Hepatitis B virus reactivation in a patient with chronic GVHD after allogeneic peripheral blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704457

Reverse seroconversion of hepatitis B virus after hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704457

Lamivudine treatment for reverse seroconversion of hepatitis B 4 years after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704457

Hepatitis B virus DNA contains a glucocorticoid-responsive element

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704457

Detection of reactivation and genetic mutations of the hepatitis B virus in patients with chronic hepatitis B infections receiving hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704457

Allogeneic bone marrow transplantation for a patient complicated by chronic hepatitis due to precore mutant hepatitis B virus: failure of management with interferon-alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704457

Fatal reactivation of precore mutant hepatitis B virus associated with fibrosing cholestatic hepatitis after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704457

Successful antiviral treatment for fulminant reactivated hepatitis B after autologous stem cell transplantation and prophylaxis during subsequent allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704457

HBeAg-negative hepatitis B in a previously thalassemic patient during immunosuppressive therapy for chronic GVHD

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704457

7 January 2021

Clinical and biochemical reactivation of HBV infection in a thalassemic patient after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704457

7 January 2021

A preliminary trial of lamivudine for chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704457

7 January 2021

Lamivudine resistance inimmunocompetent chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704457

7 January 2021

Prevalence of markers of hepatitis B in the adult German population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704457

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1704457

1 reference

Dimensions Publication ID

15 December 2017

1008449988

0 references

1 reference